Invention Grant
US07683030B2 Methods of treating diabetes with albumin-conjugated exendin peptides
有权
用白蛋白结合的毒蜥外泌肽治疗糖尿病的方法
- Patent Title: Methods of treating diabetes with albumin-conjugated exendin peptides
- Patent Title (中): 用白蛋白结合的毒蜥外泌肽治疗糖尿病的方法
-
Application No.: US12046038Application Date: 2008-03-11
-
Publication No.: US07683030B2Publication Date: 2010-03-23
- Inventor: Kathryn S. Prickett , Andrew A. Young
- Applicant: Kathryn S. Prickett , Andrew A. Young
- Applicant Address: US CA San Diego
- Assignee: Amylin Pharmaceuticals, Inc.
- Current Assignee: Amylin Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Connolly Bove Lodge & Hutz LLP
- Main IPC: A61K38/38
- IPC: A61K38/38 ; A61K38/28 ; A61K38/00
Abstract:
Modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.
Public/Granted literature
- US20080176802A1 Methods of Use for Conjugated Exendin Peptides Public/Granted day:2008-07-24
Information query
IPC分类:
